| Acquirer | Target | Price |
|---|---|---|
| Novartis AG | Selexys Pharmaceuticals Corp. | $665 million |
| Allergan plc | Chase Pharmaceuticals | $125 million |
| Magellan Health, Inc. | Veridicus Holdings, LLC | $74.5 million |
| Sun Pharma | JSC Biosintez | $60 million |
| QuintilesIMS | TKL Research's clinical trials division | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
